Reviews of Physiology, Biochemistry and Pharmacology

 
Edition number: 1st ed. 2020
Publisher: Springer
Date of Publication:
Number of Volumes: 1 pieces, Book
 
Normal price:

Publisher's listprice:
EUR 149.79
Estimated price in HUF:
61 810 HUF (58 867 HUF + 5% VAT)
Why estimated?
 
Your price:

49 448 (47 094 HUF + 5% VAT )
discount is: 20% (approx 12 362 HUF off)
Discount is valid until: 30 June 2024
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
 
Availability:

Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Can't you provide more accurate information?
 
  Piece(s)

 
Short description:

CXC Chemokine Receptors in the Tumor Microenvironment and an Update of Antagonist Development 
Yang Xun, Hua Yang, Jiekai Li, Fuling Wu, and Fang Liu

Molecular Mechanisms of Fuchs and Congenital Hereditary Endothelial Corneal Dystrophies 
Darpan Malhotra and Joseph R. Casey

Promising Anti-Atherosclerotic Effect of Berberine; Evidence from in Vitro, in Vivo, and Clinical Studies 
Alireza Fatahian, Saeed Mohammadian Haftcheshmeh, Sara Azhdari, Helaleh Kaboli Farshchi, Banafsheh Nikfar, and Amir Abbas Momtazi-Borojeni

Ion channels in glioma malignancy 
Luigi Catacuzzeno, Luigi Sforna, Vincenzo Esposito, Cristina Limatola, and Fabio Franciolini

Long description:
Leading researchers are specially invited to provide a complete understanding of a key topic within the multidisciplinary fields of physiology, biochemistry and pharmacology. In a form immediately useful to scientists, this periodical aims to filter, highlight and review the latest developments in these rapidly advancing fields.?
Table of Contents:
1. CXC Chemokine Receptors in the Tumor Microenvironment and an Update of Antagonist Development.- 2. Molecular Mechanisms of Fuchs and Congenital Hereditary Endothelial Corneal Dystrophies.- 3. Promising Anti-Atherosclerotic Effect of Berberine; Evidence from in Vitro, in Vivo, and Clinical Studies.- 4. Ion channels in glioma malignancy.